David Johnson (Australia)

This e-mail address is being protected from spambots. You need JavaScript enabled to view it

David Johnson is currently Director of Renal Medicine at Princess Alexandra Hospital, Brisbane, Australia, Professor of Medicine and Professor of Population Health at University of Queensland, Chair of the Queensland Statewide Renal Clinical Network, Chair of the CARI Guidelines Working Parties on Peritoneal Dialysis Adequacy, Evaluation of Renal Function and Management of early CKD, Chair of the Kidney Check Australia Taskforce, Co-Chair of the Australasian Creatinine and eGFR Consensus Working Party, Co-Chair of the Australasian Proteinuria Consensus Working Party, Founding Member and Deputy Chair of the Australasian Kidney Trials Network (based at Princess Alexandra Hospital), Founding Member of the NHMRC-endorsed Cardiovascular and Renal Centre of Clinical Research Excellence, Member of the ANZDATA Registry Peritoneal Dialysis Working Group and International Society of Peritoneal Dialysis Councillor. He is the principal investigator on a number of large, multi-centre randomised controlled trials, including the balANZ, IDEAL, HERO, AVATAR, IMPENDIA and HONEYPOT trials. He has published over 370 original manuscripts in peer-reviewed journals and presented over 270 abstracts at national and international scientific meetings. He has won numerous research awards for his clinical and basic science studies in the areas of peritoneal dialysis outcomes, cardiovascular risk factor modification in uraemia, renal transplantation, dialysis unit infection control, treatment of acute renal failure and mechanisms of progressive chronic kidney disease. In 2005, he was awarded the TJ Neale Award by the Australian and New Zealand Society of Nephrology for “outstanding contributions to nephrologic science.” He was a Queensland finalist in the Australian of the Year Awards for 2009.

Mandate

The International Studies Committee exists to encourage high quality, international research collaborations. Many problems in PD can only be answered effectively by such collaborative ventures, especially when large numbers of patients are required. The committee, which comprises a clinical research representative from each continent, undertakes to conduct peer review of research proposals, and subsequently endorsement by the society where appropriate. Studies currently endorsed are IDEAL, the GLOBAL Fluid Study and the International Paediatric Peritonitis Registry. Small grants ($5-10,000) have been awarded at the discretion of Council to help enable these projects, in the context of additional funding obtained by the researchers. Those wishing to approach the committee with a research proposal are encouraged to discuss this informally first with the chair, email: This e-mail address is being protected from spambots. You need JavaScript enabled to view it . The committee would hope to endorse at least one project per year.

Downloadable file for how to submit study for ISPD support.

Membership

• 5-6 members including the Chair representing a minimum of 4 continents, and at least one Council member.

• As appointed by Council

• David Johnson, AUSTRALIA

• John Burkart, USA
• Wim Van Biesen, Belgium
• Carol Pollock, Australia
• Chiu-ching Huang, Taiwan
• Nick Topley, UK